1. Home
  2. LUMO vs ABLV Comparison

LUMO vs ABLV Comparison

Compare LUMO & ABLV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LUMO
  • ABLV
  • Stock Information
  • Founded
  • LUMO 2011
  • ABLV 2015
  • Country
  • LUMO United States
  • ABLV China
  • Employees
  • LUMO N/A
  • ABLV N/A
  • Industry
  • LUMO Biotechnology: Pharmaceutical Preparations
  • ABLV
  • Sector
  • LUMO Health Care
  • ABLV
  • Exchange
  • LUMO Nasdaq
  • ABLV Nasdaq
  • Market Cap
  • LUMO 37.7M
  • ABLV 38.1M
  • IPO Year
  • LUMO N/A
  • ABLV N/A
  • Fundamental
  • Price
  • LUMO $4.33
  • ABLV $0.88
  • Analyst Decision
  • LUMO Buy
  • ABLV
  • Analyst Count
  • LUMO 4
  • ABLV 0
  • Target Price
  • LUMO $9.38
  • ABLV N/A
  • AVG Volume (30 Days)
  • LUMO 126.3K
  • ABLV 12.9K
  • Earning Date
  • LUMO 11-07-2024
  • ABLV 01-01-0001
  • Dividend Yield
  • LUMO N/A
  • ABLV N/A
  • EPS Growth
  • LUMO N/A
  • ABLV 18.07
  • EPS
  • LUMO N/A
  • ABLV 0.24
  • Revenue
  • LUMO $2,205,000.00
  • ABLV $148,999,819.00
  • Revenue This Year
  • LUMO $184.11
  • ABLV N/A
  • Revenue Next Year
  • LUMO N/A
  • ABLV N/A
  • P/E Ratio
  • LUMO N/A
  • ABLV $3.66
  • Revenue Growth
  • LUMO 300.59
  • ABLV 2.58
  • 52 Week Low
  • LUMO $1.37
  • ABLV $0.67
  • 52 Week High
  • LUMO $4.58
  • ABLV $3.94
  • Technical
  • Relative Strength Index (RSI)
  • LUMO 56.58
  • ABLV 42.79
  • Support Level
  • LUMO $4.25
  • ABLV $0.82
  • Resistance Level
  • LUMO $4.44
  • ABLV $0.94
  • Average True Range (ATR)
  • LUMO 0.12
  • ABLV 0.05
  • MACD
  • LUMO -0.03
  • ABLV 0.00
  • Stochastic Oscillator
  • LUMO 33.33
  • ABLV 35.67

About LUMO Lumos Pharma Inc.

Lumos Pharma Inc is a biopharmaceutical company that develops treatments for cancer and rare diseases. It carries out both clinical-stage and preclinical research on a range of molecules that help the immune system fight off cancer cells. The treatments are available orally and can be used in conjunction with other cancer therapies. The company also researches an Ebola vaccine. Lumos contracts with manufacturing organizations to make their treatments, engages in partnerships with pharmaceutical companies, and operates in the United States.

About ABLV Able View Global Inc.

Able View Global Inc operates as a brand management partner of international beauty and personal care brands in China. It provides full-service solutions covering marketing plan, branding, digital and social marketing, omni-channel sales, customer service, overseas logistics, warehouse, and fulfillment. The firm generates revenue from product sales by distributing and selling cross-border products from various brand owners to Chinese consumers.

Share on Social Networks: